TY  - JOUR

T1  - EE162 Cost Consequence Analysis of Using the Elecsys Anti-Müllerian Hormone Plus Immunoassay as Part of Polycystic Ovary Syndrome Assessment in the United Kingdom

JO  - Value in Health

UR  - https://doi.org/10.1016/j.jval.2024.10.446

PY  - 2024/12/01

AU  - Garay U

AU  - Olziersky AM

AU  - Laven J

AU  - Mawson R

AU  - Piltonen T

AU  - Franks S

AU  - Sillman J

ED  - 

DO  - DOI: 10.1016/j.jval.2024.10.446

PB  - Elsevier BV

VL  - 27

IS  - 12

SP  - S85

EP  - S85

Y2  - 2025/08/28

ER  -